Nanwei Tong

5.7k total citations
124 papers, 2.4k citations indexed

About

Nanwei Tong is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Nanwei Tong has authored 124 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Endocrinology, Diabetes and Metabolism, 38 papers in Molecular Biology and 29 papers in Surgery. Recurrent topics in Nanwei Tong's work include Diabetes Treatment and Management (27 papers), Metabolism, Diabetes, and Cancer (21 papers) and Pancreatic function and diabetes (19 papers). Nanwei Tong is often cited by papers focused on Diabetes Treatment and Management (27 papers), Metabolism, Diabetes, and Cancer (21 papers) and Pancreatic function and diabetes (19 papers). Nanwei Tong collaborates with scholars based in China, Australia and United States. Nanwei Tong's co-authors include Qingguo Lü, Lizhi Tang, Fang Zhang, Rahul Rathod, Shashank Joshi, Sanjay Kalra, Eberhard Standl, Parag Shah, Yuwei Zhang and Yuzhen Tong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Nanwei Tong

117 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nanwei Tong China 25 1.1k 779 407 323 300 124 2.4k
Young Seol Kim South Korea 29 725 0.7× 568 0.7× 361 0.9× 487 1.5× 308 1.0× 106 2.4k
Zhigang Zhao China 10 1.3k 1.3× 642 0.8× 406 1.0× 375 1.2× 594 2.0× 29 2.8k
Xueyao Han China 24 882 0.8× 810 1.0× 399 1.0× 398 1.2× 291 1.0× 126 2.0k
Cecilia C. Low Wang United States 14 866 0.8× 430 0.6× 443 1.1× 253 0.8× 258 0.9× 39 1.8k
Hai‐Lu Zhao China 28 547 0.5× 734 0.9× 557 1.4× 386 1.2× 348 1.2× 79 2.6k
Raffaele Galiero Italy 27 995 0.9× 612 0.8× 420 1.0× 387 1.2× 630 2.1× 58 2.3k
Qifu Li China 31 1.2k 1.1× 715 0.9× 828 2.0× 550 1.7× 513 1.7× 157 3.0k
Xiaoling Cai China 27 1.1k 1.0× 697 0.9× 439 1.1× 278 0.9× 309 1.0× 185 2.7k
José T. Real Spain 24 824 0.8× 462 0.6× 704 1.7× 531 1.6× 469 1.6× 124 2.5k

Countries citing papers authored by Nanwei Tong

Since Specialization
Citations

This map shows the geographic impact of Nanwei Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanwei Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanwei Tong more than expected).

Fields of papers citing papers by Nanwei Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanwei Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanwei Tong. The network helps show where Nanwei Tong may publish in the future.

Co-authorship network of co-authors of Nanwei Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Nanwei Tong. A scholar is included among the top collaborators of Nanwei Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanwei Tong. Nanwei Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Jinfang, Li Mao, Lingxiao Yang, et al.. (2025). Pancreatic Islet Cell Hormones: Secretion, Function, and Diabetes Therapy. MedComm. 6(9). e70359–e70359. 1 indexed citations
2.
3.
Wang, Yu, Pijun Yan, Yi Li, et al.. (2024). Association between the Fatty Liver Index (FLI) and incident coronary heart disease: insights from a cohort study on the Chinese population. Frontiers in Endocrinology. 15. 1367853–1367853. 2 indexed citations
4.
Zhang, Ruining, et al.. (2024). Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 16(1). 99–99. 22 indexed citations
5.
Peng, Ge, Zhe Yan, Yuqi Liu, et al.. (2023). The effects of first-line pharmacological treatments for reproductive outcomes in infertile women with PCOS: a systematic review and network meta-analysis. Reproductive Biology and Endocrinology. 21(1). 24–24. 12 indexed citations
6.
Zhao, Lijun, Yutong Zou, Yucheng Wu, et al.. (2023). Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes. Frontiers in Endocrinology. 14. 1103251–1103251. 3 indexed citations
7.
Xie, Qingxing, Xinyi Zhang, Jinfang Ma, et al.. (2023). Effect of iodine nutritional status on the recurrence of hyperthyroidism and antithyroid drug efficacy in adult patients with Graves’ disease: a systemic review. Frontiers in Endocrinology. 14. 1234918–1234918. 4 indexed citations
8.
Zhang, Fan, Di Teng, Nanwei Tong, et al.. (2022). Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study from China. Thyroid. 32(5). 571–580. 13 indexed citations
9.
Liu, Yuqi, Ismael Valladolid‐Acebes, Juan Li, et al.. (2022). ATF5 is a regulator of ER stress and β-cell apoptosis in different mouse models of genetic- and diet-induced obesity and diabetes mellitus. Cellular Signalling. 102. 110535–110535. 5 indexed citations
10.
Zhang, Fang, et al.. (2022). Coexistence of Graves’ disease and primary hyperparathyroidism: a case description. Quantitative Imaging in Medicine and Surgery. 12(5). 3014–3019.
11.
12.
Chen, Xiaoting, Lei Wu, Ye Zhou, et al.. (2021). Identification of MDM2, YTHDF2 and DDX21 as potential biomarkers and targets for treatment of type 2 diabetes. Biochemical and Biophysical Research Communications. 581. 110–117. 7 indexed citations
13.
Lü, Qingguo, Xuan Li, Jia Liu, et al.. (2019). AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases. Bioscience Reports. 39(2). 56 indexed citations
14.
Ma, Hui, Huiping Tian, Hongjie Yu, et al.. (2019). Effects of acarbose and metformin on the inflammatory state in newly diagnosed type 2 diabetes patients: a one-year randomized clinical study. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Fang, Zhang, Lizhi Tang, Yuwei Zhang, Qingguo Lü, & Nanwei Tong. (2017). Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials. Scientific Reports. 7(1). 15997–15997. 18 indexed citations
16.
Zhang, Yu-Wei, et al.. (2015). [Epidemiology Study and Risk Factors Analysis of Hyperuricemia in Tibetan Monks of Sichuan Province].. PubMed. 46(5). 759–63, 769. 1 indexed citations
17.
18.
Fang, Jiajia, Sihan Chen, Nanwei Tong, et al.. (2012). Metabolic syndrome among Chinese obese patients with epilepsy on sodium valproate. Seizure. 21(8). 578–582. 42 indexed citations
19.
Wang, Chun, Yi Liu, Yucheng Chen, et al.. (2009). Severe insulin allergy after percutaneous transluminal coronary angioplasty. Clinical Therapeutics. 31(3). 569–574. 1 indexed citations
20.
Lü, Qingguo, Nanwei Tong, Yupu Liu, et al.. (2009). Community-based population data indicates the significant alterations of insulin resistance, chronic inflammation and urine ACR in IFG combined IGT group among prediabetic population. Diabetes Research and Clinical Practice. 84(3). 319–324. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Young Seol Kim Breakdown of academic impact, for papers by Zhigang Zhao Breakdown of academic impact, for papers by Xueyao Han Breakdown of academic impact, for papers by Cecilia C. Low Wang Breakdown of academic impact, for papers by Hai‐Lu Zhao Breakdown of academic impact, for papers by Raffaele Galiero Breakdown of academic impact, for papers by Qifu Li Breakdown of academic impact, for papers by Xiaoling Cai Breakdown of academic impact, for papers by José T. Real
Rankless by CCL
2026